Division Photo
Row 1: T Crombleholme, R Dasgupta, R Falcone, F Lim, R Brown, S Keswani
Row 2: M Helmrath, H Jones, M Levitt, F Ryckman, D von Allmen, T Jenkins
Row 3: J Frischer, L Martin, A Peña, S Barnett
Division Highlights
Molecular Fetal Lab - Timothy Crombleholme, MD
Dr. Crombleholme has expertise in wound healing and fetal cellular and molecular therapeutics research. Dr. Crombleholme is the Director, Surgical Research and Associate Chair of the Children’s Hospital Research Foundation and the Medical Director of the Fetal Care Center.
Solid Organ Cancers - Jason Frischer, MD
Dr. Frischer is continuing his basic science research to study solid organ cancers by identifying, and then overcoming, the mechanisms by which they become resistant to current therapies. Dr. Frischer is the ECMO Director. He intends on applying for a K08 in the fall of 2011.
Intestinal Rehabilitation - Michael Helmrath, MD
Dr. Helmrath has expertise in intestinal rehabilitation. His basic science research continues to focus on intestinal failure and intestinal stem cells. He is studying the mechanisms of intestinal stem cell expansion following resection. His research will help better understand how the cells that continually renew the lining of the intestine every day (intestinal stem cells) increase in number to help compensate following intestinal loss. His research continues to be funded by the NIH as an R01. He has submitted a second R01 which is pending.
Bariatric Surgery - Thomas Inge, MD
The Center for Bariatric Research and Innovation directed by Dr. Inge continues to partner with NIDDK and lead the national effort to prospectively gather data and publish evidence-based recommendations for use of weight loss surgery in adolescents. The team received a renewal of their NIH U01 funded Teen LABS Study, the largest multicenter study to document outcomes of adolescents undergoing weight loss surgery. In addition to this parent grant, the study group has added numerous other R01-funded ancillary studies to the consortium. Dr. Inge also received ARRA funding for Assessing the Health Benefits and Risks of Adolescent Bariatric patients. He has submitted a NIH Competitive renewal to continues this important research.
Molecular Fetal Therapy - Sundeep Keswani, MD
Dr. Keswani’s is focusing on the molecular mechanisms underlying the fetal regenerative wound healing phenotype. If goals are realized, it may yield a wide range of therapeutics for diseases characterized by excessive fibroplasia. His basic science interests in fetal wound healing are closely paired with his clinical practice in fetal surgery and he is currently leading an initiative to create a clinical center of excellence in pediatric wound care. He has submitted his first successful K08 application to the National Institute of Health and is awaiting formal notification of the award.
Biliary Atresia - Gregory Tiao, MD
Dr. Tiao continues to develop his research in biliary atresia. Dr. Tiao received funding on his R01 submission during the past year as he continues his research career progression. Dr. Tiao is the Surgical Director for Liver and Intestinal Transplantation.
Jaimie D. Nathan, MD
Dr. Nathan's research focus is to elucidate the role of the gut microbiome in the modulation of liver injury and cholangiopathies. His studies involve a novel mouse model of small bowel bacterial overgrowth, in which a small bowell self-filling blind loop is surgically created. With this model, he is studying the gut-liver axis as it relates to the pathogenesis of a number of cholangiopathies which can progress to end-stage liver disease. He intends on applying for a K08 in the spring of 2012.
Fetal Therapy - Helen Jones, PhD
Dr. Jones is enhancing the research ongoing in the Center for Molecular Fetal Therapy (CMFT) alongside Dr. Habli. Dr. Jones continues to develop distinct research efforts as well as supporting the rest of the CMFT.
Significant Accomplishments
Intestinal Rehabilitation
Michael Helmrath, MD, has expertise in intestinal rehabilitation. His basic science research continues to focus on intestinal failure and intestinal stem cells. He is studying the mechanisms of intestinal stem cell expansion following resection. His research is funded by the National Institutes of Health as an R01. Also, he has submitted a second R01 that is pending. His research will help better understand how the cells (intestinal stem cells) that renew the lining of the intestine every day increase in number to help compensate following intestinal loss.
Bariatric Surgery
Thomas Inge, MD, PhD, directs the Center for Bariatric Research and Innovation, which partners with the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to lead the national effort to prospectively gather data and publish evidence-based recommendations for use of weight loss surgery in adolescents. The Teen LABS study continues to be funded by the NIDDK, the largest multicenter study to document outcomes of adolescents undergoing weight loss surgery. He has submitted a competitive renewal to continue this important research.
Wound Healing
Sundeep Keswani, MD, is focusing on the molecular mechanisms underlying the fetal regenerative wound healing phenotype. If goals are realized, his work may yield a wide range of therapeutics for diseases characterized by excessive fibroplasia. His basic science interests in fetal wound healing are closely paired with his clinical practice in fetal surgery and he is leading an initiative to create a clinical center of excellence in pediatric wound care. He has submitted his first K08 application to the National Institutes of Health.
Biliary Atresia
Gregory Tiao, MD, continues to develop his research in biliary atresia. Tiao received funding on his R01 submission during the past year.